[1]
|
Sohar, E., Gafni, J., Pras, M. and Heller, H. (1967) Familial Mediterranean fever: A survey of 470 cases and review of the literature. American Journal of Medicine, 43, 227-253.
|
[2]
|
Hashkes, P.J. (2002) Amyloidosis and familial Mediterranean fever. In: Rudolph, C.D., Rudolph, A.M., Hostetter, M.K., Lister, G., S?egel, N.J. (eds), Rudolph’s Pediatrics (21st Editon), McGraw-Hill, New York, 864-866.
|
[3]
|
Pras, M., Zemer, D., Langewitz, P. and Sohar, E. (1992) Familial Mediterranean fever: A genetic disorder prevalent in Sepharadi Jews. In: Bonne-Tamir, B., Adam, A. (eds), Genetic Diversity Among Jews: Diseases and Markers at the DNA Level, Oxford University Press, Oxford, 223-227.
|
[4]
|
Oz?akar, Z.B., Yal?inkaya, F., Yüksel, S., Acar, B., G?kmen, D. and Ekim, M. (2006) Possible effect of subclinical inflammation on daily life in familial Mediterranean fever. Clinical Rheumatology, 25, 149-152.
|
[5]
|
Yudkin, J.S. (2003) Adipose tissue, insulin action and vascular disease: Inflammatory signals. International Journal of Obesity and Related Metabolic Disorders, 27, 25-28.
|
[6]
|
Das, U.N. (2001) Is obesity an inflammatory condition? Nutrition, 17, 953-966.
|
[7]
|
Savgan-Gürol, E., Kasap?opur, O., Hatemi, S., Ercan, O., Caliskan, S., Sever, L., Ozdogan, H. and Arisoy, N. (2001) Growth and IGF-1 levels of children with familial Mediterranean fever on colchicine treatment. Clinical and Experimental Rheumatology, 19, 72-75.
|
[8]
|
Türkmen, M., Soylu, O.B., Kasap, B., Güne?, S., Tüfek?i, O., Soylu, A., Er?al, D. and Kavuk?u, S. (2008) Growth in familial mediterranean fever: Effect of attack rate, genotype and colchicine treatment. Journal of Pediatric Endocrinology and Metabolism, 21, 789-792.
|
[9]
|
Zung, A., Barash, G., Zadik, Z. and Barash, J. (2006) Familial Mediterranean fever and growth: Effect of disease severity and colchicine treatment. Journal of Pediatric Endocrinology and Metabolism, 19, 155-160.
|
[10]
|
Onen, F., Sumer, H., Turkay, S., Akyurek, O., Tunca, M. and Ozdogan, H. (2004) Increased frequency of familial Mediterranean fever in Central Anatolia, Turkey. Clinical and Experimental Rheumatology, 22, 31-33.
|
[11]
|
Bundak, R., Furman, A., Gunoz, H., Darendeliler, F., Bas, F. and Neyzi, O. (2006) Body mass index references for Turkish children. Acta Paediatrica, 95, 194-198.
|
[12]
|
Livneh, A., Langevitz, P., Zemer, D., Kees, S. and Lidav, T. (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis and Rheumatism, 40, 1879-1885.
|
[13]
|
Du?unsel, R., Dursun, I., Gündüz, Z., Poyrazo?lu, M.H., Gürg?ze, M.K. and Dundar, M. (2008) Genotype- phenotype correlation in children with familial Mediterranean fever in a Turkish population. Pediatrics International, 50, 208-212.
|
[14]
|
World Health Organisation (1998) Obesity: Preventing and managing the global epidemic. Report of A WHO Consultation, Geneva, 3-5 June 1997 (WHO/NT/98.1).
|
[15]
|
Kocaoglu, B.A. and K?ksal, O. (1985) The effect of socioeconomic conditions on growth, development and obesity among adolescents in Turkey. Journal of Nutrition and Dietetics, 14, 25-37.
|
[16]
|
Cinaz, P., ?amurdan, O. and Maral, I. (2003) 6-16 ya? aras? 12.589 ?ocukta obezite s?kl??? ve risk fakt?rleri. VIII. Ulusal Pediatrik Endokrinoloji Kitab?, 230.
|
[17]
|
Simsek, E., Akpinar, S., Bahcebasi, T., Senses, D.A. and Kocabay, K. (2008) The prevalence of overweight and obese children aged 6-17 years in the West Black Sea region of Turkey. International Journal of Clinical Practice, 62, 1033-1038.
|
[18]
|
Simon, D., Fernando, C., Czernichow, P. and Prieur, A.M. (2002) Linear growth and final height in patients with systemic juvenile idiopathic arthritis treated with longterm glucocorticoids. Journal of Rheumatology, 29, 1296-1300.
|
[19]
|
Campfield, L.A., Smith, F.J., Guisez, Y., Devos, R. and Burn, P. (1995) Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science, 269, 546-549.
|
[20]
|
Halaas, J.L., Gajiwala, K.S., Maffei, M., Cohen, S.L., Chait, B.T., Rabinowitz, D., Lallone, R.L., Burley, S.K. and Friedman, J.M. (1995) Weight-reducing effects of the plasma protein encoded by the obese gene. Science, 269, 543-546.
|
[21]
|
Ahima, R.S., Saper, C.B., Flier, J.S. and Elmquist, J.K. (2000) Leptin regulation of neuroendocrine systems. Front Neuroendocrinol, 21, 263-307.
|
[22]
|
Ronti, T., Lupattelli, G. and Mannarino, E. (2006) The endocrine function of adipose tissue: An update. Clinical Endocrinology, 64, 355-365.
|
[23]
|
Winer, J.C., Zern, T.L., Taksali, S.E., Dziura, J., Cali, A.M., Wollschlager, M., Seyal, A.A., Weiss, R., Burgert, T.S. and Caprio, S. (2006) Adiponectin in childhood and adolescent obesity and its association with inflammatory markers and components of the metabolic syndrome. Journal of Pediatric Endocrinology and Metabolism, 91, 4415-4423.
|
[24]
|
Saltevo, J., Laakso, M., Jokelainen, J., Kein?nen- Kiukaanniemi, S., Kumpusalo, E. and Vanhala, M. (2008) Levels of adiponectin, C-reactive protein and interleukin-1 receptor antagonist are associated with insulin sensitivity: A population-based study. Diabetes/Metabolism Research and Reviews, 24, 378-383.
|
[25]
|
Antuna-Puente, B., Feve, B., Fellahi, S. and Bastard, J.P. (2008) Adipokines: The missing link between insulin resistance and obesity. Diabetes and Metabolism, 34, 2-11.
|
[26]
|
Shin, J.H., Shin, D.W. and Noh, M. (2009) Interleukin-17A inhibits adipocyte differentiation in human mesenchymal stem cells and regulates pro-inflammatory responses in adipocytes. Biochemical Pharmacology, 77, 1835-1844.
|